Razieh Dehbanipour

Razieh Dehbanipour

Auto-generated profile, based on publicly available information

Razieh Dehbanipour

Department of Microbiology, School of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

26 October 2021 in Annals of Clinical Microbiology and Antimicrobials
Verified
Journal Article
Open access
PDF file
NNNeda Yousefi Nojookambari
Neda Yousefi Nojookambari
MSMehrzad Sadreddinamin
Mehrzad Sadreddinamin
RDRazieh Dehbanipour
Razieh Dehbanipour
ZGZohreh Ghalavand
Zohreh Ghalavand
GEGita Eslami
Gita Eslami
SYSajjad Yazdansetad
Sajjad Yazdansetad
Background: β-Lactam antibiotics have been broadly used for the treatment of Acinetobacter baumannii infections, resulting in development of β-lactam inactivating β-lactamases. Here, we described antibiotic resistance rate, prevalence of β-lactamase-encoding genes, and clonal relationships of A. baumannii strains isolated from children referred to Children’s Medical Center in Tehran, Iran, during 2019–2020. Methods: A total of 60 non-replicate A. baumannii isolates were recovered from clinical specimens of pediatric patients. Antibiotic susceptibility testing was done by the disc diffusion method. Colistin susceptibility of isolates was performed by the broth microdilution method. β-lactamase-encoding genes were characterized by PCR. The presence of ISAba1 element upstream of the several oxacillinase genes was also checked. Genetic relatedness of isolates was determined by using random amplification of polymorphic DNA (RAPD) typing. Results: The antimicrobial susceptibility tests showed that 83.3% of A. baumannii isolates were MDR, and 40% XDR. Both MDR and XDR A. baumannii isolates were susceptible to colistin. The frequency of blaOXA-51-like, blaOXA-23-like, blaTEM, blaOXA-24-like, blaPER, blaSHV, blaCTX-M, blaOXA-58-like, and blaIMP was 100, 93.33, 60, 36.67, 28.33, 8.33, 5, 3.33, and 1.67%, respectively. Coexistence of ISAba1/blaOXA-23-like and ISAba1/blaOXA-51-like was observed in 65% and 85% of isolates, respectively. RAPD analysis revealed 4 common types and 2 single types of A. baumannii isolates. Conclusions: The multiple clones harboring blaOXA-23-like, ISAba1-blaOXA-51-like, and ISAba1-blaOXA-23-like were responsible for the spread of A. baumannii isolates in our clinical wards. Dissemination of the well-established clones is worrisome and would become therapeutic challenges due to the possible transferring genetic elements associated with resistance.

10 August 2022 in Current Microbiology
Verified
Journal Article
Closed access
PDF file
ZGZohreh Ghalavand
Zohreh Ghalavand
GEGita Eslami
Gita Eslami
AHAli Hashemi
Ali Hashemi
MSMehrzad Sadreddinamin
Mehrzad Sadreddinamin
NYNeda Yousefi
Neda Yousefi
RDRazieh Dehbanipour
Razieh Dehbanipour

2 March 2026 in Annals of Clinical Microbiology and Antimicrobials
Verified
Journal Article
Open access
PDF file
FSFatemeh Sefati
Fatemeh Sefati
RDRazieh Dehbanipour
Razieh Dehbanipour
MGMohammad Amin Ghatee
Mohammad Amin Ghatee
ASAsghar Sharifi
Asghar Sharifi
SKSeyed Abdolmajid Khosravani
Seyed Abdolmajid Khosravani
This study investigates the prevalence of hypervirulent Klebsiella pneumoniae (hvKp) in clinical isolates, emphasizing hypermucoviscosity, virulence-relate

1 January 2026 in International Journal of Dentistry
Verified
Journal Article
Open access
PDF file
SMSeyedeh Zahra Miri
Seyedeh Zahra Miri
AAArash Asfaram
Arash Asfaram
RDRazieh Dehbanipour
Razieh Dehbanipour
MMMobina Moeindoost
Mobina Moeindoost
FKFatemeh Khajehzadeh
Fatemeh Khajehzadeh
Background and Objective: Due to escalating concerns regarding bacterial resistance and the adverse effects associated with chlorhexidine, natural antimicrobial agents have gained significant attention as potential alternatives. The present study aimed to evaluate the in vitro antibacterial activity of the hydroalcoholic extract of Amygdalus scoparia ( A. scoparia ) gum against primary oral streptococci and Staphylococcus aureus , comparing its efficacy with chlorhexidine and conventional antibiotics. Materials and Methods: The hydroalcoholic extract of A. scoparia gum was tested against standard and clinical isolates of Streptococcus mutans ( S. mutans ), Streptococcus sobrinus ( S. sobrinus ), Streptococcus sanguinis ( S. sanguinis ), and S. aureus . Antibacterial activity was assessed using the agar well diffusion method to determine the zone of inhibition (ZOI) and the broth microdilution method to determine the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC). Chlorhexidine (0.2%) and antibiotics (vancomycin and penicillin) served as positive controls. All experiments were performed in triplicate. Results: The A. scoparia extract demonstrated significant antibacterial activity against all tested microorganisms. Notably, the extract produced a significantly larger ZOI against clinical isolates of S. mutans (9.40 ± 0.97 mm) compared with chlorhexidine (8.50 ± 1.08 mm; p = 0.0448). Although chlorhexidine exhibited the lowest MIC and MBC values (2.00–13.33 µg/mL), the plant extract showed moderate inhibitory effects (MIC range: 10.67–250.00 mg/mL), particularly against cariogenic streptococci. Overall, clinical isolates demonstrated greater resistance than standard strains. Conclusion: The hydroalcoholic extract of A. scoparia gum exhibited promising antibacterial activity against key oral pathogens, especially clinical isolates of S. mutans , showing comparable or superior efficacy to chlorhexidine in agar diffusion assays. These findings suggest that this extract holds potential as a natural adjunct or alternative antimicrobial agent in oral healthcare products.